 |
 |
||||||
 |
Our customers' Feedback |
Your cart
€0.00 (0 items)
| |||||
Cancer
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
- Fruit and vegetables do not reduce overall cancer risk, review concludes
Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people.
- Hope and controversy over prostate cancer screening
Screening older men with the PSA blood test could cut prostate cancer deaths by around half, according to a new study.
- Multivitamins may boost breast cancer risk
Women who regularly take multivitamins have a higher risk of breast cancer than women who don’t, according to a large new study.
- Experimental vaccine extends life of men with prostate cancer
A vaccine that primes the immune system to attack prostate cancer can extend the lives of men in the advanced stages of the disease, researchers say.
- Treatments for advanced prostate cancer
We haven’t looked at the research on treatments for advanced prostate cancer in the same way as we have for other treatments on our site.
Our billing is certified by:
- Breast cancer kills older women more often - Fox News
Daily MailBreast cancer kills older women more oftenFox NewsPrint Email Share Comments Recommend Tweet Breast cancer is often considered more deadly among younger women, but a new study shows older women are actually more likely to die of the disease.
- Burnley chairman Kilby reveals cancer battle behind decision to step down - Daily Mail
Daily MailBurnley chairman Kilby reveals cancer battle behind decision to step downDaily MailBy Sportsmail Reporter Burnley chairman Barry Kilby has revealed a battle with cancer is behind his decision to stand down from his position at the npower Championship club.
- Is India well equipped to battle cancer? - IBNLive.com
thatsCricketIs India well equipped to battle cancer?IBNLive.
- Pa. woman gets probation for fake cancer claims - USA TODAY
Pa.
- FDA rewards Roche with priority review for blockbuster cancer drug - FierceBiotech
FDA rewards Roche with priority review for blockbuster cancer drugFierceBiotechAfter racking up a solid set of late-stage data on the experimental breast cancer drug pertuzumab late last year, Roche and Genentech scored priority review status for the program, shaving months off of the regulatory process as it drives toward a .
|
|
Copyright © 2005-2012 Canadian Pharmacy Online Canada Pharmacy, Canadian Pharmacy. www.canadianpharmacyonline.biz is an affiliate marketing website |